Pacira BioSciences' Change in Accured Expenses fell 3267.77% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.0 million, marking a year-over-year decrease of 14783.65%. This contributed to the annual value of $11.7 million for FY2024, which is 15317.85% up from last year.
According to the latest figures from Q3 2025, Pacira BioSciences' Change in Accured Expenses is $7.5 million, which was down 3267.77% from -$19.4 million recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Change in Accured Expenses ranged from a high of $22.5 million in Q4 2021 and a low of -$25.1 million during Q1 2023
Its 5-year average for Change in Accured Expenses is -$1.7 million, with a median of -$113000.0 in 2021.
As far as peak fluctuations go, Pacira BioSciences' Change in Accured Expenses plummeted by 864070.8% in 2022, and later soared by 20205.66% in 2023.
Quarter analysis of 5 years shows Pacira BioSciences' Change in Accured Expenses stood at $22.5 million in 2021, then plummeted by 83.53% to $3.7 million in 2022, then increased by 11.18% to $4.1 million in 2023, then tumbled by 120.06% to -$826000.0 in 2024, then soared by 1011.62% to $7.5 million in 2025.
Its Change in Accured Expenses stands at $7.5 million for Q3 2025, versus -$19.4 million for Q2 2025 and $4.7 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value